| Ultra-high performance liquid chromatography tandem mass spectrometric method for the determination of tamoxifen, N-desmethyltamoxifen, 4-hydroxytamoxifen and endoxifen in … MV Antunes, S Raymundo, V de Oliveira, DE Staudt, G Gössling, ... Talanta 132, 775-784, 2015 | 61 | 2015 |
| Influence of CYP2D6 and CYP3A4 phenotypes, drug interactions, and vitamin D status on tamoxifen biotransformation MV Antunes, TA da Fontoura Timm, V de Oliveira, DE Staudt, ... Therapeutic drug monitoring 37 (6), 733-744, 2015 | 40 | 2015 |
| CYP3A4*22 is Related to Increased Plasma Levels of 4-Hydroxytamoxifen and Partially Compensates for Reduced CYP2D6 Activation of Tamoxifen MV Antunes, V De Oliveira, S Raymundo, DE Staudt, G Gössling, ... Pharmacogenomics 16 (6), 601-617, 2015 | 32 | 2015 |
| Current scenario of clinical cancer research in Latin America and the Caribbean G Gössling, TF Rebelatto, C Villarreal-Garza, AS Ferrigno, D Bretel, ... Current Oncology 30 (1), 653-662, 2023 | 14 | 2023 |
| Outcomes and prognostic factors of patients with metastatic colorectal cancer who underwent pulmonary metastasectomy with curative intent: a Brazilian experience GCL Gössling, MF Chedid, FS Pereira, RK Silva, LB Andrade, N Peruzzo, ... The Oncologist 26 (9), e1581-e1588, 2021 | 12 | 2021 |
| Development, validation and clinical application of a HPLC-FL method for CYP2D6 phenotyping in South Brazilian breast cancer patients MV Antunes, DE Staudt, S Raymundo, V de Oliveira, G Gössling, R Pirolli, ... Clinical biochemistry 47 (12), 1084-1090, 2014 | 12 | 2014 |
| Combination immunotherapy for pancreatic cancer: challenges and future considerations GCL Gössling, DB Zhen, VG Pillarisetty, EG Chiorean Expert Review of Clinical Immunology 18 (11), 1173-1186, 2022 | 7 | 2022 |
| Evaluation of dried blood spots as an alternative matrix for therapeutic drug monitoring of abiraterone and delta (4)-abiraterone in prostate cancer patients TLD Weiss, G Gössling, MV Antunes, G Schwartsmann, R Linden, ... Journal of Pharmaceutical and Biomedical Analysis 195, 113861, 2021 | 7 | 2021 |
| Socioeconomic impact of cancer in Latin America and the Caribbean G Werutsky, G Goessling, RA Pellegrini, GAS Ampuero, T Rebelatto Archives of Medical Research 53 (8), 818-825, 2022 | 4 | 2022 |
| Clinicopathological characterization, FGFR alteration prevalence, and outcomes of locally advanced or metastatic urothelial cancer in Latin America (LACOG 1518). VC Souza, A Soares, FC Maluf, FSM Monteiro, R Gidekel, ... Journal of Clinical Oncology 40 (16_suppl), e16549-e16549, 2022 | 3 | 2022 |
| Clinical validation and diagnostic accuracy of 99mTc-EDDA/HYNIC-TOC compared to 111In-DTPA-octreotide in patients with neuroendocrine tumours: the LACOG 0214 study CM Moriguchi-Jeckel, RR Madke, G Radaelli, A Viana, P Nabinger, ... ecancermedicalscience 17, 2023 | 2 | 2023 |
| A quick UPLC–MS/MS method for therapeutic drug monitoring of abiraterone and delta (4)‐abiraterone in human plasma TLD Weiss, CM Furtado, MV Antunes, G Gössling, G Schwartsmann, ... Biomedical Chromatography 34 (11), e4947, 2020 | 2 | 2020 |
| Health Services Access Inequalities in Brazil Result in Poorer Outcomes for Stage III NSCLC—RELANCE/LACOG 0118 VCC de Lima, A Gelatti, JFP Moura, AF Fares, G de Castro Jr, C Mathias, ... JTO clinical and research reports 5 (3), 100646, 2024 | 1 | 2024 |
| A national survey of current scenario and future perspectives of cancer research in Brazil. H Resende, TF Rebelatto, G Werutsky, GCL Gössling, V Aguiar, G Lopes, ... Journal of Clinical Oncology 41 (16_suppl), e18721-e18721, 2023 | 1 | 2023 |
| Abstract OT2-22-02: Sequencing of anthracyclines and taxanes during neoadjuvant therapy of locally advanced HER2-negative breast cancer (NEOSAMBA Study/LACOG 0419) T Reinert, CP Souza, P Liedke, G Werutsky, L Testa, V Antunes, C Barrios, ... Cancer Research 83 (5_Supplement), OT2-22-02-OT2-22-02, 2023 | 1 | 2023 |
| Rat-tailed maggot urinary myiasis N Peruzzo, R Siegle, RD Tesche, G Gössling, LF Sperb, PG Buiar, ... Journal of Travel Medicine 30 (2), taad016, 2023 | 1 | 2023 |
| Current scenario and future perspectives of clinical research in Brazil: a national survey H Resende, TF Rebelatto, G Werutsky, G Gossling, VQ Aguiar, ... ecancermedicalscience 17, 2023 | 1 | 2023 |
| Neoadjuvant itraconazole (I) in patients (pts) with resectable basal cell carcinoma (BCC): A phase II multistage study. RP Pereira, SJ Azevedo, J Cé Coelho, TF Rebelatto, GL Viapiana, ... Journal of Clinical Oncology 38 (15_suppl), e22081-e22081, 2020 | 1 | 2020 |
| Treatment delay and outcomes in stage IV lung cancer: The reality of a public hospital in a developing country. N Peruzzo, J Ce Coelho, G Gössling, PG Buiar, GS Macedo, G Lenz, ... Journal of Clinical Oncology 37 (15_suppl), e20709-e20709, 2019 | 1 | 2019 |
| O impacto do acompanhamento regular na evolução de pacientes asmáticos KMM Dias, LLA Silva, GC Borges Junior, GCL Gössling, MAF Moreira Revista HCPA. Porto Alegre, 2011 | 1 | 2011 |
